Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

181 trials

NCT05897320
Recruiting
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Phase 3 · Argentina, Canada, Spain, United Kingdom, Italy, Mexico, Poland, Portugal, Serbia, United States · 60 sites
Registry update: 14 Oct 2026
NCT05654012
Recruiting
Migraine in Adolescents
Not applicable · United States · 1 site
Registry update: 13 Jul 2026
NCT05711394
Recruiting
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Phase 3 · Belgium, Canada, Denmark, Spain, France, United Kingdom, Hungary, Israel, Italy, Japan, Netherlands, Poland, Puerto Rico, Romania, Sweden, United States · 104 sites
Registry update: 6 Oct 2026
NCT05814497
Recruiting
Supraspinal Processing of Sensory Aspects of Pain
Not applicable · United States · 1 site
Registry update: 5 Jun 2026
NCT05907655
Recruiting
Study of the Glymphatic System in Migraine
Not applicable · Italy · 1 site
Registry update: 6 Nov 2026
NCT07022496
Recruiting
Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals
Phase 4 · Egypt · 1 site
Registry update: 15 Jun 2025
NCT05780450
Recruiting
Effectiveness of Transcranial Direct Current in Patients With Persistent COVID-19 With Headaches and Chronic Pain.
Not applicable · Spain · 2 sites
Registry update: 15 Oct 2026
NCT05752396
Recruiting
Overlapping Pain Trajectory Study
Not applicable · United States · 1 site
Registry update: 20 Oct 2026
NCT05598723
Recruiting
BOTOX® vs. XEOMIN® for Chronic Migraine
Phase 3 · United States · 1 site
Registry update: 22 Jul 2026
NCT04930887
Recruiting
Clinical Trial of Endoscopically Guided Injection of Exparel (Bupivacaine) for the Treatment of Craniofacial Pain
Phase 2 · United States · 1 site
Registry update: 27 Apr 2026
NCT05769348
Recruiting
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
Not applicable · United States · 1 site
Registry update: 25 Feb 2026
NCT05158894
Recruiting
Observational Study to Assess Adverse Events When Adult Female Participants Are Treated With Ubrelvy (Ubrogepant) or Qulipta (Atogepant) During Pregnancy
Not applicable · Canada, United States · 2 sites
Registry update: 15 Dec 2025
NCT05570149
Recruiting
EptinezuMaB in ReAl-world evidenCE: Multicenter, Real Life, Cohort Study in Migraine.
Not applicable · Italy · 1 site
Registry update: 1 May 2025
NCT06674772
Recruiting
Molecular Phenotyping of Migraine Patients According to Sex and Age Through CGRP Quantification
Not applicable · Spain · 1 site
Registry update: 13 Nov 2024
NCT05334927
Recruiting
China HeadAche DIsorders RegiStry
Not applicable · China · 61 sites
Registry update: 10 Jul 2026
NCT05582837
Recruiting
Treatment of Meniere's Disease With Migraine Medications
Phase 4 · United States · 1 site
Registry update: 22 Jun 2026
NCT05415020
Recruiting
Determining the Utility of a Behavioral Intervention in Chronic Migraine
Not applicable · United States · 1 site
Registry update: 8 Jun 2026
NCT05306899
Recruiting
Multi-center RCT of IV Ketamine Efficacy and Safety in Chronic Daily Headaches
Phase 3 · Canada · 2 sites
Registry update: 8 Jun 2026
NCT05342493
Recruiting
Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
Not applicable · Japan · 1 site
Registry update: 22 Jun 2026
NCT07103694
Recruiting
i-NEED: NEw migrainE Drugs Database
Not applicable · Italy · 2 sites
Registry update: 11 Jun 2026

Ordered by registry start date. Freshness and sponsorship never change the order.